Jason is a co-founder of The Nashton Company. The Nashton Company is a holding company investing in recurring revenue services businesses. Nashton builds leading companies in niche markets over a very long period of time
Prior to cofounding the firm, Jason served as the President of Vector Disease Acquisition, a holding company that provides vector-borne disease prevention programs and lake management services. Under Jason's leadership, the company made 14 acquisitions and grew at a CAGR of 43%. Vector Disease Acquisition was acquired by Rentokil Initial (FTSE: RTO) in November of 2017.
Jason obtained a Master in Business Administration degree from Harvard Business School and a BBA in finance from the University of Massachusetts Amherst.